amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule
amlodipine
RxCUI: 898350
What the CMS Formulary Data Shows for amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule
Per the CMS 2026 Part D formulary file, amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule (RxNorm concept RXCUI 898350, generic name amlodipine) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.1.
Real-world access to amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 27.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 11,575,402 Part D beneficiaries filled amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule in 2023, with total plan-and-beneficiary spending of $407,233,375 and an average per-beneficiary annual cost of $35.18. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule today.
Coverage Details
- Formularies covering
- 330
- Plans covering
- 5,067
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 27.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 11,575,402
- Total spending
- $407,233,375
- Avg per beneficiary
- $35.18
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T1 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule
98 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule covered by Medicare Part D?
Yes, amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule is covered by 5,067 Medicare Part D plans (100% of all Part D formularies).
What tier is amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule on Medicare Part D plans?
amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule averages Tier 2.1 across Part D plans, ranging from Tier 1 to Tier 6.
Does amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule require prior authorization?
0% of Part D formularies require prior authorization for amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule. Step therapy: 0%. Quantity limits: 27.6%.
How much does Medicare spend on amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule?
In 2023, total Medicare Part D spending on amlodipine 2.5 MG / benazepril hydrochloride 10 MG Oral Capsule was $407,233,375, covering 11,575,402 beneficiaries. The average spend per beneficiary was $35.18.
Read our methodology - how this data is sourced, computed, and verified.